drugset / Trial / NCT05089942

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

NCT05089942

Phase 4 Unknown 16 enrolled Zhejiang Provincial People's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to investigate the efficacy,safety, and tolerability of the recombinant human insulin patch ZJSRM2021 in healthy subjects, type 1diabetes mellitus and type 2diabetes mellitus patients

Timeline

Start
2021-12
Primary completion
2021-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic